The forecast for the import of antibiotics into France shows a steady increase from 2024 through 2028, with a consistent annual rise in monetary value from 909.14 million USD in 2024 to 956.87 million USD in 2028. This equates to an approximate year-on-year growth rate of around 1.34%. Accounting for the past five years, the compound annual growth rate (CAGR) reflects a stable upward trend in imports.
Future trends to watch include the potential impact of technological advancements in pharmaceutical manufacturing, alterations in regulatory policies affecting antibiotics, and shifts in global health priorities that could affect demand. Additionally, changes in trade agreements and currency fluctuations could also influence import levels.
